Nektar Therapeutics

Nektar Therapeutics, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company.

As of now, Nektar Therapeutics has not established any science-based targets or commitments to reduce emissions, nor does it inherit any emissions data from a parent company. This lack of publicly available information suggests that the company may still be in the early stages of developing its climate strategy and emissions reporting framework.

In the broader context of the biopharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction initiatives. Nektar Therapeutics may benefit from aligning with industry standards and practices to enhance its environmental commitments in the future.